McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its U.S. pharmaceutical segment, which includes branded and specialty drugs.

After reducing its footprint in Connecticut in recent years, pharmaceutical giant McKesson Corp. plans to close ... the spokesman said. The distributor, which relocated its headquarters from ...

We recently published a list of the 30 Growing Dividend Stocks with Low PE Ratios. In this article, we are going to take a ...

McKesson (MCK) has been one of the most searched ... Over the past month, shares of this prescription drug distributor have returned +5.8%, compared to the Zacks S&P 500 composite's -2.9% change.

McKesson Corporation (NYSE:MCK) is one of the largest pharmaceutical distributors in the U.S., supplying both branded and generic drugs along with medical technology and surgical supplies.

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and ...

McKesson Corporation (NYSE ... clinical services and distribution offerings. Additionally, McKesson will release its fourth quarter and full year fiscal 2025 financial results after market ...